Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence
Inserm · Université de Versailles Saint-Quentin-en-Yvelines · +129 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
559
total citations
- FWCI
- 27.36
- Percentile
- 100%
- References
- 69
Citations per year
Authors
102- JBJean BousquetCorresponding
Inserm, Université de Versailles Saint-Quentin-en-Yvelines, Humboldt-Universität zu Berlin, Vieillissement et Maladies Chroniques. Approches Epidémiologiques et de santé publique, Assistance Publique – Hôpitaux de Paris, Gefluc Languedoc Roussillon, Hôpital Sainte-Périne
- HJHolger J. Schünemann
McMaster University
- ATA. Togias
National Institute of Allergy and Infectious Diseases
- CBClaus Bachert
Ghent University Hospital
- MEMartina Erhola
Finnish Institute for Health and Welfare
Topics & keywords
Topics
Keywords
- Medicine
- Grading (engineering)
- Asthma
- Randomized controlled trial
- Intensive care medicine
- Allergen immunotherapy
- Allergy
- Immunology
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.
Funding
- AAmgen
- PPfizer
- AAstraZeneca
- GGlaxoSmithKline
- MMerck
- NNovartis
- SSanofi
- TPTeva Pharmaceutical Industries
- FHF. Hoffmann-La Roche
- CFChiesi Farmaceutici
- CBCSL Behring
- RPRegeneron Pharmaceuticals
- RERespiratory Effectiveness Group
- ITImmune Tolerance Network
- OOtonomy
- MMylan
- ATAllergy Therapeutics
- BLBritish Lung Foundation
- SShionogi
- STStiftung Tierärztliche Hochschule Hannover
- SServier
- GPG. Pohl-Boskamp
- ARAKL Research and Development
- GGenentech
- AAllergopharma
- SGSanofi Genzyme
- EAEfficacy and Mechanism Evaluation Programme